A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer’s disease

A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer’s disease

Chaihu Shugan San (CSS) is a well-known herbal formula used to nourish liver and blood, promote blood circulation and Qi flow in Traditional Chinese Medicine. Modern pharmacological studies and clinical uses showed that CSS could ameliorate cognitive dysfunction of Alzheimer’s disease (AD). The pres...

Full description

Bibliographic Details
Main Authors:	Qiang Zeng, Longfei Li, Wingsum Siu, Yu Jin, Meiqun Cao, Weifeng Li, Jian Chen, Weihong Cong, Min Ma, Keji Chen, Zhengzhi Wu
Format:	Article
Language:	English
Published:	Elsevier 2019-12-01
Series:	Biomedicine & Pharmacotherapy
Subjects:	Chaihu Shugan San Alzheimer’s disease Network pharmacology Multi-target effects
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332219325077

Similar Items

Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San
by: Zhang S, et al.
Published: (2021-08-01)

Chaihu-Shugan-San (Shihosogansan) alleviates restraint stress-generated anxiety and depression in mice by regulating NF-κB-mediated BDNF expression through the modulation of gut microbiota
by: Sang-Kap Han, et al.
Published: (2021-08-01)

Chaihu-Shugan-San and absorbed meranzin hydrate induce anti-atherosclerosis and behavioral improvements in high-fat diet ApoE-/- mice via anti-inflammatory and BDNF-TrkB pathway
by: Lan Li, et al.
Published: (2019-07-01)

Influence of progestational stress on BDNF and NMDARs in the hippocampus of male offspring and amelioration by Chaihu Shugan San
by: Ya-hui Xu, et al.
Published: (2021-03-01)

Network pharmacology and experimental studies for deciphering the molecular targets and mechanisms of Chaihu Shugan powder in the treatment of functional dyspepsia
by: Jiang, K., et al.
Published: (2023)

Chaihu-Shugan-San exerts an antidepressive effect by downregulating miR-124 and releasing inhibition of the MAPK14 and Gria3 signaling pathways
by: Qiong Liu, et al.
Published: (2018-01-01)

Research on the mechanism of Chaihu Huangqin medicine based on integrated pharmacology to improve the clinical symptoms of COVID-19
by: Huan-Le Fang, et al.
Published: (2020-06-01)

Comparative Pharmacokinetics of Naringin in Rat after Oral Administration of Chaihu-Shu-Gan-San Aqueous Extract and Naringin Alone
by: Hong-Wu Zhang, et al.
Published: (2013-09-01)

Bile duct perfusion of Chaihu Paishi Decoction combined with duodenoscopy in treatment of difficult choledocholithiasis
by: TANG Tengqian, et al.
Published: (2021-02-01)

Chaihu Guizhi Ganjiang Decoction Ameliorates Pancreatic Fibrosis via JNK/mTOR Signaling Pathway
by: Lihua Cui, et al.
Published: (2021-06-01)

Shugan Decoction Alleviates Colonic Dysmotility in Female SERT-Knockout Rats by Decreasing M3 Receptor Expression
by: Yinshu Wang, et al.
Published: (2020-09-01)

Potential Molecular Mechanisms of Chaihu-Shugan-San in Treatment of Breast Cancer Based on Network Pharmacology
by: Kunmin Xiao, et al.
Published: (2020-01-01)

Study on the Mechanism of Shugan Xiaozhi Fang on Cells with Non-alcoholic Fatty Liver Disease
by: Xing Yufeng, et al.
Published: (2019-12-01)

Chaihu-Shugan-San administration ameliorates perimenopausal anxiety and depression in rats.
by: Shujiao Chen, et al.
Published: (2013-01-01)

Effect of Xiao Chaihu Tang combined with intravenous chemotherapy on tumor markers and immune function in patients with advanced breast cancer
by: Jian-Ping Zhong
Published: (2017-05-01)

Improved Resting-State Functional Dynamics in Post-stroke Depressive Patients After Shugan Jieyu Capsule Treatment
by: Guanqun Yao, et al.
Published: (2020-04-01)

Involvement of NMDA-AKT-mTOR Signaling in Rapid Antidepressant-Like Activity of Chaihu-jia-Longgu-Muli-tang on Olfactory Bulbectomized Mice
by: Xing Wang, et al.
Published: (2019-01-01)

Improving Depressive Symptoms of Post-stroke Depression Using the Shugan Jieyu Capsule: A Resting-State Functional Magnetic Resonance Imaging Study
by: Li, J., et al.
Published: (2022)

Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer’s disease
by: Qihui Wu, et al.
Published: (2020-09-01)

Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
by: Yunxia Luo, et al.
Published: (2020-04-01)

Effects of Chaihu-Shugan-San and Shen-Ling-Bai-Zhu-San on p38 MAPK Pathway in Kupffer Cells of Nonalcoholic Steatohepatitis
by: Qin-He Yang, et al.
Published: (2014-01-01)

Searching the cytochrome p450 enzymes for the metabolism of meranzin hydrate: a prospective antidepressant originating from Chaihu-Shugan-San.
by: Xi Huang, et al.
Published: (2014-01-01)

A Comparison Study of Chaihu Shugan San and Fluoxetine on Antidepression and Regulating Blood Rheology Effects with Chronic Restrained Stress Rats
by: Meng Qian, et al.
Published: (2020-01-01)

Modified Chaihu Shugan Powder for Functional Dyspepsia: Meta-Analysis for Randomized Controlled Trial
by: Nan Yang, et al.
Published: (2013-01-01)

Anti-endometriosis Mechanism of Jiawei Foshou San Based on Network Pharmacology
by: Yi Chen, et al.
Published: (2018-07-01)

Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway
by: Yinji Liang, et al.
Published: (2018-01-01)

A network pharmacology approach to discover active compounds and action mechanisms of San-Cao Granule for treatment of liver fibrosis
by: Wei S, et al.
Published: (2016-02-01)

Antidepressant-Like Effects and Cognitive Enhancement of Coadministration of Chaihu Shugan San and Fluoxetine: Dependent on the BDNF-ERK-CREB Signaling Pathway in the Hippocampus and Frontal Cortex
by: Lijing Yan, et al.
Published: (2020-01-01)

Chaihu-Shugan-San Reinforces CYP3A4 Expression via Pregnane X Receptor in Depressive Treatment of Liver-Qi Stagnation Syndrome
by: Zehui He, et al.
Published: (2019-01-01)

An Integrated Pharmacology-Based Analysis for Antidepressant Mechanism of Chinese Herbal Formula Xiao-Yao-San
by: Naijun Yuan, et al.
Published: (2020-03-01)

Effect of Chaihu Shugan Powder-Contained Serum on Glutamate-Induced Autophagy of Interstitial Cells of Cajal in the Rat Gastric Antrum
by: Ren-Qian Tan, et al.
Published: (2019-01-01)

Binding between Saikosaponin C and Human Serum Albumin by Fluorescence Spectroscopy and Molecular Docking
by: Yi-Cun Chen, et al.
Published: (2016-01-01)

Ethnopharmacokinetic- and Activity-Guided Isolation of a New Antidepressive Compound from Fructus Aurantii Found in the Traditional Chinese Medicine Chaihu-Shugan-San: A New Approach and Its Application
by: Rong Fan, et al.
Published: (2012-01-01)

Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis
by: Siliang Wang, et al.
Published: (2021-07-01)

Huang-Qi San improves glucose and lipid metabolism and exerts protective effects against hepatic steatosis in high fat diet-fed rats
by: Yan Li, et al.
Published: (2020-06-01)

Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders
by: E. G. Mendelevich
Published: (2018-11-01)

A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Paeonia lactiflora Pall. On the Treatment of Alzheimer’s Disease
by: Qiang Zeng, et al.
Published: (2019-01-01)

Yupingfeng San Inhibits NLRP3 Inflammasome to Attenuate the Inflammatory Response in Asthma Mice
by: Xue Liu, et al.
Published: (2017-12-01)

A Strategy for Optimizing the Combination of Active Components Based on Chinese Medicinal Formula Sheng-Mai-San for Myocardial Ischemia
by: Fang Li, et al.
Published: (2018-02-01)

Gut Microbiota Is the Key to the Antidepressant Effect of Chaihu-Shu-Gan-San
by: Meng Yu, et al.
Published: (2020-02-01)